[go: up one dir, main page]

DK0527760T3 - Fremgangsmåder og præparater til vaccination mod HIV - Google Patents

Fremgangsmåder og præparater til vaccination mod HIV

Info

Publication number
DK0527760T3
DK0527760T3 DK91907077.1T DK91907077T DK0527760T3 DK 0527760 T3 DK0527760 T3 DK 0527760T3 DK 91907077 T DK91907077 T DK 91907077T DK 0527760 T3 DK0527760 T3 DK 0527760T3
Authority
DK
Denmark
Prior art keywords
methods
preparations
against hiv
vaccination against
env
Prior art date
Application number
DK91907077.1T
Other languages
English (en)
Inventor
Timothy J Gregory
Phillip W Berman
Brian M Fendly
Florian M Wurm
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24007729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0527760(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0527760T3 publication Critical patent/DK0527760T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91907077.1T 1990-04-03 1991-04-01 Fremgangsmåder og præparater til vaccination mod HIV DK0527760T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50478590A 1990-04-03 1990-04-03

Publications (1)

Publication Number Publication Date
DK0527760T3 true DK0527760T3 (da) 1995-11-27

Family

ID=24007729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91907077.1T DK0527760T3 (da) 1990-04-03 1991-04-01 Fremgangsmåder og præparater til vaccination mod HIV

Country Status (10)

Country Link
US (2) US5674984A (da)
EP (1) EP0527760B1 (da)
JP (1) JP3494300B2 (da)
AT (1) ATE125157T1 (da)
AU (2) AU647108B2 (da)
CA (1) CA2078546A1 (da)
DE (1) DE69111440T2 (da)
DK (1) DK0527760T3 (da)
NZ (1) NZ237666A (da)
WO (1) WO1991015238A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
EP0554401A4 (en) * 1990-10-26 1996-10-30 New York Health Res Inst Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
NZ267838A (en) 1993-06-07 1997-12-19 Genentech Inc Preparation of an hiv gp 120 subunit vaccine involving determining a neutralising epitope in the v2 and/or c4 domains
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US5997861A (en) * 1994-10-31 1999-12-07 Burstein Laboratories, Inc. Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6271198B1 (en) 1996-11-06 2001-08-07 Genentech, Inc. Constrained helical peptides and methods of making same
US6121021A (en) 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
US6289229B1 (en) * 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
PT1141315E (pt) 1998-12-31 2008-05-05 Novartis Vaccines & Diagnostic Polipéptidos do envelope (env) de hiv modificados
JP2002533124A (ja) 1998-12-31 2002-10-08 カイロン コーポレイション Ｈｉｖポリペプチドの改善された発現およびウイルス様粒子の生成
AU784635B2 (en) 1999-11-16 2006-05-18 Geneart Ag The genome of the HIV-1 inter-subtype (C/B') and use thereof
EP2412242A3 (en) 2001-07-05 2012-06-13 Novartis Vaccines and Diagnostics, Inc. Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
DE10255508A1 (de) * 2002-11-27 2004-06-17 Forschungszentrum Jülich GmbH Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
CA2525641A1 (en) 2003-05-12 2004-11-25 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against fiv infection
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
US20110150911A1 (en) * 2003-11-19 2011-06-23 Qui-Lim Choo Methods and reagents for treating, preventing and diagnosing bunyavirus infection
EP2382988A1 (en) 2006-03-31 2011-11-02 Novartis AG Combined mucosal and parenteral immunization against HIV
US7892759B2 (en) * 2007-02-16 2011-02-22 Drexel University Enhanced sensitivity of a cantilever sensor via specific bindings
US8512947B2 (en) 2007-02-16 2013-08-20 Drexel University Detection of nucleic acids using a cantilever sensor
KR102319842B1 (ko) 2009-10-26 2021-11-01 에프. 호프만-라 로슈 아게 글리코실화된 면역글로불린의 제조 방법
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN102552904A (zh) * 2010-12-23 2012-07-11 徐州医学院附属医院 人类免疫缺陷病毒膜分子gp120功能域与人TGF-β1的重组分子
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CA3102859A1 (en) 2018-07-03 2020-01-09 Gilead Sciences, Inc. Antibodies that target hiv gp120 and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
DE3588134T2 (de) * 1984-12-24 1997-03-20 Genentech Inc Fusionen von AIDS-verwandten Polypeptiden
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU3775789A (en) * 1988-06-10 1990-01-05 Applied Biotechnology, Inc. A method of evaluating recombinant vaccines against immunodeficiency virus
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
CA2066607A1 (en) * 1989-09-22 1991-03-23 Thomas Kieber-Emmons Peptides associated with the cd4 binding region of gp120 and their methods of use
EP0519001B2 (en) * 1990-03-09 2007-12-19 Novartis Vaccines and Diagnostics, Inc. PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
WO1993020104A1 (en) * 1992-03-31 1993-10-14 The Public Health Research Institute Of The City Of New York, Inc. Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120

Also Published As

Publication number Publication date
AU5055593A (en) 1994-01-27
WO1991015238A1 (en) 1991-10-17
EP0527760A1 (en) 1993-02-24
CA2078546A1 (en) 1991-10-04
AU647108B2 (en) 1994-03-17
US5674984A (en) 1997-10-07
EP0527760B1 (en) 1995-07-19
JPH05505611A (ja) 1993-08-19
AU7584791A (en) 1991-10-30
US5849533A (en) 1998-12-15
JP3494300B2 (ja) 2004-02-09
ATE125157T1 (de) 1995-08-15
NZ237666A (en) 1997-08-22
DE69111440D1 (de) 1995-08-24
DE69111440T2 (de) 1996-03-28

Similar Documents

Publication Publication Date Title
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
ATE328068T1 (de) Papillomavirus vakzine
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
MX9203439A (es) Una citocina mamifera, il-11
DE60144145D1 (de) Subtilisin-variante
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
DK0771213T3 (da) Haemophilus influenza adhærens- og penetrationsproteiner
DK0480949T4 (da) Fremstilling af virusvaccine
ITRM920350A1 (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DE69634077D1 (de) Haemophilus adhäsionsproteinen
DE69728897D1 (de) Saeugetierchemokine
DE69736779D1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
EP0652769A1 (en) Vaccines against Metazoon parasites.
ATE294237T1 (de) S?ugetier thymokingene
DK0854727T3 (da) Tumorafstødelsesantigener, der præsenteres af HLA-B44-molekyler, og anvendelser af samme
DK205188D0 (da) Proteinprotease-inhibitorer af streptomyces
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
NO924087L (no) Antistoffer, fremgangsmaate for deres fremstilling og anvendelse dera
ATE62019T1 (de) Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren.
SE8604921D0 (sv) Rengoringsprodukt